MAS Advisors’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,664
Closed -$201K 88
2023
Q1
$201K Buy
+8,664
New +$201K 0.2% 79
2022
Q3
Sell
-39,704
Closed -$822K 107
2022
Q2
$822K Sell
39,704
-10,490
-21% -$234K 0.74% 40
2022
Q1
$1.22M Sell
50,194
-1,000
-2% -$24.7K 0.93% 36
2021
Q4
$1.42M Buy
+51,194
New +$1.41M 1.04% 31

Other funds holding SENT

MAS Advisors's SENT Position: Q2 2023 in Review

MAS Advisors sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q2 2023, closing a stake of 8,664 shares — an estimated $201K sold.

MAS Advisors first reported a position in SENT in Q4 2021 and held it in 4 quarters. The position peaked at $1.42M in Q4 2021. 7 funds tracked by Wall St. Rank hold SENT as of Q2 2023.

  • MAS Advisors reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q2 2023 after selling out during the quarter.
  • MAS Advisors sold 8,664 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q2 2023, an estimated $201K.
  • MAS Advisors first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q4 2021 and held it in 4 quarters.
  • MAS Advisors's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $1.42M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q2 2023.

Based on MAS Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.